administration of the drug ( 30 mg per day for one week ) resulted in the decrease of noradrenaline excretion , blood free fatty acid level , and in lowering of blood pressure and heart rate , particularly in patients with ischemic heart disease and hyperkinetic syndrome .
C0028351
noradrenaline
C0020649
lowering